LCC in Italian: Resectable EGFR-mutant NSCLC

Episode
363
Soundcloud
Share

As part of IASLC’s ongoing series of podcasts in world languages, Dr. Alfredo Addeo moderates a Virtual Tumor Board discussion with Dr. Andrea Fillipi and Dr. Piergiorgio Solli. The tumor board focuses on the management of resectable EGFR-mutant NSCLC.

Guest
 Alfredo Addeo
Alfredo Addeo

MD

Head of Oncology Service
University Hospital of Geneva
Andrea R. Filippi
Andrea R. Filippi

MD

Head of Radiation Oncology, Associate Professor, Radiation Therapy
Fondazione Istituto Nazionale dei Tumori, Milan
Department of Oncology, University of Milan
Piergiorgio Solli
Piergiorgio Solli

MD, PhD

Head of Thoracic Surgery
IRCCS Fondazione Istituto Nazionale dei Tumori, Milan